Multiplexed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiplexed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiplexed Today - Breaking & Trending Today

TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-200-A0201 Targeting HPV16 to Treat Solid Tumors

TSC-200-A0201 is TScan’s third cleared IND for the T-Plex solid tumor program supporting the use of multiple TCRs in combination to deliver customized, multiplexed TCR-T cell therapies based on. | June 6, 2023 ....

Debora Barton , Heather Savelle , Gavin Macbeath , Joyce Allaire , Company Immunobank , Drug Administration , Globe Newswire Tscan Therapeutics Inc , Securities Exchange , Lifesci Advisors , Tscan Therapeutics Inc , Chief Medical , Chief Executive Officer , Private Securities Litigation Reform Act , Securities Exchange Act , Financial Condition , Annual Report , Sci Advisors , Tscan Therapeutics , Nc Stock Exchange , Press Release , Ased Tcrx Us89854m1018 ,

PathogenDx, Inc.: PathogenDx Expands Reach of Its Patented Multiplexed Molecular Testing Technology, Bringing It to the Clinical, Food and Agriculture Sectors

Company's Novel "Dynamic Dimensional Detection" Array Technology Delivers Unprecedented Performance in Multiplexing, Turn-Around Time, Throughput and Cost Per Test
Scottsdale, Arizona (Newsfile Corp. ....

United States , Ellen Mellody , Jonathan Goss , Michela Proto , Pathogendx Or Company , Arizona Newsfile Corp , Technology Delivers Unprecedented Performance , Turn Around Time , Cost Per , Dimensional Detection , Pathogendx Co Founder ,

TScan Therapeutics Announces FDA Clearance of Three Investigational New Drug Applications for the Treatment of Solid Tumors

Primary IND for solid tumor program, T-Plex, supports simultaneous use of multiple TCRs to create customized, multiplexed TCR-T cell therapies based on target and HLA expression INDs for. | January 23, 2023 ....

Davidp Southwell , Tscan Immunobank , Gavin Macbeath , Heather Savelle , Joyce Allaire , Tscan Therapeutics Inc , Lifesci Advisors , Securities Exchange , Drug Administration , Company Immunobank , Chief Scientific , Chief Executive Officer , Private Securities Litigation Reform Act , Securities Exchange Act , Financial Condition , Annual Report , Sci Advisors , Tscan Therapeutics , Nc Stock Exchange , Press Release , Nds Tcrx Us89854m1018 ,

InDevR, Inc.: InDevR Launches Highly Multiplexed Kit for Rapid Pneumococcal Vaccine Characterization

BOULDER, Colo., May 10, 2022for rapid and accurate assessment of pneumococcal vaccines at all stages of manufacturing, including multivalent drug product. This launch is accompanied by the availability ....

South Mimms , United Kingdom , David Boyle , Terry Salyer , Kostenloser Wertpapierhandel , Erica Dawson , Melinda Gates Foundation , Image For Indevr Inc , Regulatory Agency , Laboratory Director , Vaxarray Pneumococcal Assay , Vaxarray Platform , Pneumococcal Assay , Vaxarray Pneumococcal Kit , Vaxarray Pneumococcal ,

RevoluGen Ltd.: Quadram Scientists Demonstrate Advantages of Fire Monkey HMW-DNA Extraction with Multiplexed Oxford Nanopore DNA Sequencing for Complete Hybrid Assemblies of Pathogen Genomes

Data presented at Microbiology Society Annual Conference, Belfast, 4-7 April 2022 LONDON, April 5, 2022 /PRNewswire/ UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), welcomes ....

United Kingdom , City Of , Oxford Nanopore , Gemma Langridge , Sue Charles , Winniewy Lee , Mariea Chattaway , Gemmac Langridge , John Wain , Typhis Typhi , Jana Haase , Amina Ismail Ahmed , Georgios Patsos , Quadram Institute , University Of East Anglia , Head Corporate Communications , Revolugen Ltd , United Kingdom Health Security Agency , Norwich University Hospitals , Merck Kga , Quadram Institute Bioscience , Microbiology Society Annual Conference , Norwich Research Park , Sciences Research Council , Group Leader At Quadram , Merck Kgaa ,